Core One Labs Signs Definitive Agreement for Acquisition of Biosynthetic Psilocybin Research Firm Vocan Biotechnologies Inc.
VANCOUVER, BC / ACCESSWIRE / December 24, 2020 / Core One Labs Inc. (CSE:COOL), (OTC:CLABF),…
VANCOUVER, BC / ACCESSWIRE / December 24, 2020 / Core One Labs Inc. (CSE:COOL), (OTC:CLABF),…
SEATTLE–(BUSINESS WIRE)–#Anxiety–According to Coherent Market Insights, the global mental disorder treatment market is estimated to…
Market players are engaged in developing new approaches to treat several immunological disorders along with…
Public listing (CSE:NM) expected to occur on or about January 5, 2021 Not for distribution…
The Company has Now Resumed the Clinical Development of its Proposed Anti-Nausea Pharmaceutical Grade Version…
BOGOTÁ, Colombia, Dec. 24, 2020 (GLOBE NEWSWIRE) — Medcolcanna Organics Inc. (“Medcolcanna”, “MCCN” or the…
PRESS RELEASE – REGULATED INFORMATION Gosselies, Belgium, 24 December 2020, 7am CET – BONE THERAPEUTICS (Euronext…
PRESS RELEASE – REGULATED INFORMATION Article 14, first paragraph, of the Law of 2 May…
VANCOUVER, British Columbia, Dec. 23, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW)…
Leading experts to evaluate the clinical and regulatory path to approval in the US market…